 ImmuCell Corporation Nasdaq: ICCC ImmuCell or the Company, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced preliminary, unaudited product sales results for the year ended December 31, 2019. Total product sales increased by approximately 2,700,000, or 25, to approximately 13,700,000 during the year ended December 31, 2019 versus the year ended December 31, 2018. Total product sales increased by approximately 695,000, or 24, to approximately 3,600,000 during the fourth quarter ended December 31, 2019 versus the comparable period during 2018. 